NASDAQ: PASWPing An Biomedical Co Ltd Stock
$1.09-0.15 (-12.1%)
Updated Oct 2, 2025
PASW Price
$1.09
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$0.89
52 Week High
$5.40
P/E
-109x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$11.99M
Earnings
-$180.36k
Gross Margin
6.2%
Operating Margin
0.03%
Profit Margin
-1.5%
Debt to Equity
-8.91
Operating Cash Flow
$2M
Beta
2.98
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PASW Overview
A holding company (formerly covering apparel supply chain management) that is rebranding to focus on biomedical / health-biotech business. Its historical operations included supply chain, yarn/textiles, garments, logistics in apparel SCM.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PASW's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Textile
Industry Rating
D
PASW
Ranked#2 of 2
Ranked#2 of 2
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $53.60 | C | |
| $2.78 | – | |
| $4.44 | – |
Be the first to know about important PASW news, forecast changes, insider trades & much more!
PASW News
Overview
Due Diligence Score
–
Industry Average (22)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PASW scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PASW is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PASW is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
PASW's Earnings (EBIT) of $3.09k... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more PASW due diligence checks available for Premium users.
Valuation
PASW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-109x
Industry
24.1x
Market
37.19x
PASW's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PASW's Earnings (EBIT) of $3.09k... subscribe to Premium to read more.
Interest Coverage Financials
PASW's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.0M
Liabilities
$9.0M
Debt to equity
-8.91
PASW's short-term liabilities ($8.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PASW's short-term assets ($7.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PASW's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PASW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PASW's operating cash flow ($2.00M)... subscribe to Premium to read more.
Debt Coverage Financials
PASW vs Textile Stocks
Ping An Biomedical Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.